logo
Plus   Neg
Share
Email

Amgen Offers To Buy Nuevolution For SEK 32.50/shr In Cash - Quick Facts

Amgen Inc. (AMGN) said that it has offered to buy Nuevolution AB for 32.50 Swedish kronor per share in cash, valuing the company at about 1.610 billion kronor or $167 million.

The offer price represented a premium of 169% compared to the closing price of Nuevolution's shares on Nasdaq Stockholm on 21 May 2019 of 12.10 kronor.

Nuevolution's Board recommended its shareholders to accept the Offer. Nuevolution is a small molecule drug discovery platform biotech company founded in 2001, headquartered in Copenhagen, Denmark.

The acceptance period for the Offer is expected to commence on or around 13 June 2019 and expire on or around 4 July 2019. Settlement is expected to take place on or around 15 July 2019.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Global PC shipments returned to growth in the second quarter of 2020 after seeing a significant decline in the preceding first quarter due to COVID-19 related supply-chain disruptions, according to reports by two research firms. The PC market returned to growth in the quarter as production ramped up and vendors restocked their supplies to near-normal levels. The bankruptcy filing of America's oldest apparel retailer Brooks Brothers has ignited significant interest from potential buyers for the brand. WHP Global and a venture backed by Authentic Brands Group LLC and Simon Property Group, Inc., are reportedly considering bids for the retailer. WHP Global owns the ANNE KLEIN and JOSEPH ABBOUD brands. Sundial Herbal Products has recalled around 65 products, which were misbranded and currently unapproved drugs, the U.S. Food and Drug Administration said in a statement. The recall follows an order by a federal judge in June to stop distributing the company's unapproved new drugs. The affected items include herbal products and dietary supplements.
Follow RTT